• Info
  • Insider Ownership

Insider Trading & Ownership of David Bredt

Location
Boston, MA
Summary
The estimated net worth of David Bredt is at least $10.2M dollars as of November 18, 2025. David Bredt is the Chief Scientific Officer of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $10.2M.
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when David Bredt files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of David Bredt

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RAPP Rapport Therapeutics, Inc. Chief Scientific Officer $10.2M -$1.23M -10.8% Nov 17, 2025

Insider Transactions Reported by David Bredt:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.